Efficacy and Safety of Oral Immunotherapy in Children Aged 1 to 3 Years With Peanut Allergy (the Immune Tolerance Network IMPACT Trial): A Randomized Placebo-Controlled Study
Jones
SM,
Kim
EH,
Nadeau
KC. Lancet. 2022;399(10322):359–371
Source: PEDIATRICS - Category: Pediatrics Source Type: research